Rob is an intellectual property specialist, with a deep knowledge of commercial law and litigation developed through 20+ years of senior roles in multinational companies, such as Johnson & Johnson Research and Mylan, as well as private practice roles in top-tier law firms and patent and trade mark attorney firms, including Allens and Sprusons & Ferguson.
He is experienced in all aspects of protecting, commercialising and enforcing intellectual property rights across the globe. Rob has strong contentious matter capabilities and is a formidable litigator. He has conducted matters and represented clients across State and Federal jurisdictions including in the Appellate Courts.
Having worked in-house at Johnson and Johnson Research and Mylan he has an in-depth knowledge of the pharmaceutical industry. However, his experience in private practice encompasses industries as diverse as mining, medical devices, renewable energy, IT, and general commercial litigation.
Rob has acted in matters involving parties such as AI Media, Alphapharm, Apotex, Aspen, Baxalta, BHP, Bristol-Myers Squibb, Caroma Dorf, Deputy Commissioner of Taxation, Generic Partners, Glaxosmithkline, Ground Support Service, John Morris Group, Labfriend, Medtronic, News Corporation, Onesteel, Otsuka Pharmaceutical Group, Pfizer, Roche, Sandoz, Sandvik, Thermo Fisher Scientific, Quaker, Viater Medical, Warner Chilcott and many Universities.